TilrayTLRY
TLRY
About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Employees: 2,650
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
9% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 53
0.65% more ownership
Funds ownership: 10.44% [Q3] → 11.09% (+0.65%) [Q4]
1% less funds holding
Funds holding: 346 [Q3] → 344 (-2) [Q4]
6% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 88
10% less call options, than puts
Call options by funds: $20.4M | Put options by funds: $22.6M
17% less capital invested
Capital invested by funds: $162M [Q3] → $134M (-$27.2M) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$1
118%
upside
Avg. target
$1
118%
upside
High target
$1
118%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Piper Sandler Michael Lavery 37% 1-year accuracy 21 / 57 met price target | 118%upside $1 | Neutral Maintained | 9 Apr 2025 |
Financial journalist opinion
Based on 30 articles about TLRY published over the past 30 days
Positive
MarijuanaStocks
18 hours ago
April 2025's Canadian Cannabis Stock Picks: Growth and Opportunity
As the U.S. cannabis industry continues to grow, Canadian cannabis stocks are gaining momentum with investors. The U.S. market is expected to reach over $44 billion in 2025. By 2030, analysts believe it could climb to more than $75 billion. Adult-use cannabis is now legal in nearly half of the U.S. states. Many others permit medical use, creating widespread demand. At the same time, lawmakers are again discussing federal reform bills. These bills aim to provide national guidelines and unlock interstate trade. Although legalization has faced delays, investor sentiment remains optimistic. Canadian companies are preparing to scale their U.S. operations once laws change.
Neutral
Market Watch
5 days ago
Tilray's stock has been below $1 for months. Here's how it plans to fix that.
Tilray Brands Inc. said Thursday it's planning to seek shareholder approval for a reverse stock split as dramatic as 20-for-1, in a move aimed at boosting its share price back above the $1 mark.
Neutral
GlobeNewsWire
5 days ago
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails
Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this Summer Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this Summer
Neutral
GlobeNewsWire
5 days ago
Tilray Medical Introduces Cannabis Edibles in Australia
SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.
Neutral
GlobeNewsWire
5 days ago
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced a special meeting of stockholders (the “Special Meeting”) on June 10, 2025. The Special Meeting will be held via live audio webcast, which can be accessed on the investor page on Tilray.com.
Positive
MarijuanaStocks
6 days ago
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.
Negative
The Motley Fool
6 days ago
3 Crashing Stocks I Wouldn't Buy Right Now
The stock market has been crashing this year and if you're a long-term investor, it can be a good time to invest in companies at discounted valuations. But that doesn't mean that you should be investing in just any stock.
Neutral
GlobeNewsWire
1 week ago
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie , 10 Barrel Brewing Co.'s highly-crushable new 5% IPA brewed in partnership with Scout Campers. Perfect for making a livin' and doin' the best you can, Camp Coldie was born a ramblin' can!
Negative
Seeking Alpha
1 week ago
Tilray: Sell Before Potential Reverse Split
Tilray Brands' Q3 results were disappointing, with revenues falling well short of expectations and significant cash burn leading to continued dilution. The company reduced its fiscal year revenue guidance by $50 million, while the outstanding share count surged to a new high. With shares trading well below $1.00, a reverse split will likely be needed to satisfy exchange listing requirements.
Positive
Seeking Alpha
1 week ago
Tilray: Q3 Earnings Could Be The Inflection Point It Needs
Tilray's Q3 earnings show promising signs of improving fundamentals with expanding margins and effective cost management, combined with a clean balance sheet. Management's strategy shift to prioritizing profitable growth offers a viable path to long-term profitability. Despite improving fundamentals, Tilray appears to be undervalued, in my opinion.
Charts implemented using Lightweight Charts™